New 2026 Conditioning regimen for hematopoietic cell transplant in transfusion dependent thalassemia: Recommendations from the EBMT practice harmonisation and guidelines committee Group Practice Harmonisation and Guidelines Committee 1st listed author Mohammed Essa Journal Bone Marrow Transplant.
New 2026 Allogeneic hematopoietic cell transplantation from haploidentical donors with total body irradiation versus chemo-based regimens for adult AML patients in first complete remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) Group Acute Leukemia Working Party (ALWP) 1st listed author Enrico Maffini Journal Bone Marrow Transplant.
New 2026 Is the adult EBMT risk score valid and relevant for hematopoietic stem cell transplantation in children acute leukemia? Group Paediatric Diseases Working Party (PDWP) 1st listed author F Baleydier Journal Bone Marrow Transplant.
New 2026 Update of the decision-making algorithm on selecting transfusion-dependent β-thalassemic patients for gene therapy approaches: joint consensus report on behalf of EHA-specialized working group and EBMT hemoglobinopathies working party Group Haemoglobinopathies Working Party (HWP) Other society 1st listed author Lucia de Franceschi Journal Bone Marrow Transplant.
New 2026 Eltrombopag Added to Standard Immunosuppressive Treatment as Front-Line Therapy for Severe Aplastic Anemia: Long-Term Outcomes of the Phase-3 Randomized Superiority EBMT-SAAWP RACE Study Group Severe Aplastic Anaemia Working Party (SAAWP) 1st listed author Antonio M Risitano Journal Am J Hematol.
New 2026 Impact of conditioning regimen on outcomes of young AML patients ( < 40 years) undergoing HCT in complete remission, with transplant conditioning intensity score of 3.5-4.0. A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Enrico Maffini Journal Bone Marrow Transplant.
New 2026 HLA-B*15:01 and HLA-DRB1*07:01 as novel markers of acute GVHD in pediatric HSCT Group Paediatric Diseases Working Party (PDWP) 1st listed author Covida Mootoosamy Journal Bone Marrow Transplant.
New 2026 Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Bone Marrow Transplant.
New 2026 Cellular therapy in mantle cell lymphoma: recommendations from the EBMT practice harmonisation and guidelines committee Group Practice Harmonisation and Guidelines Committee 1st listed author Peter Dreger Journal Bone Marrow Transplant.
New 2026 A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemia Group Acute Leukemia Working Party (ALWP) 1st listed author Alexandros Spyridonidis Journal Bone Marrow Transplant.
New 2026 Fludarabine combined with treosulfan or total body irradiation as a conditioning therapy before allogeneic hematopoietic stem cell transplantation in acute lymphoblastic leukemia. A retrospective matched-pair analysis from the ALWP of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Ryszard Swoboda Journal Bone Marrow Transplant.
2026 The impact of IPI risk factors on CAR T-cell therapy or allogeneic stem cell transplantation for treatment of relapsed or refractory large B-cell lymphoma (LBCL) Group Lymphoma Working Party (LWP) 1st listed author Anna Ossami Saidy Journal Bone Marrow Transplant.